Oenobiol Bindor 3-in-1+ is from the latest generation of gluten-free prebiotic captors(3), capable of trapping up to 75% of calories absorbed(1), suppressing your appetite(2,4) and rebalancing the intestinal flora after 48 hours(3) for a sure-fire weight loss effect.
Oenobiol Bindor 3-in-1 is classified as a prescribed medical device under French law, indicated for weight loss and obesity prevention.
For anyone overweight who wants to lose weight.
For overweight (25 ≤ BMI < 30) adults only.
Take two gelatine capsules twice daily, immediately prior to taking lunch and dinner.
– A sense of fullness for up to four hours(2,4)
– Reduces calorie absorption by up to 75%(1)
– Effective over time: intestinal flora are rebalanced within 48 hours(3)
Take two gelatine capsules immediately prior to taking lunch and dinner. To be taken over the course of 15 consecutive days (contents of one box) which may be renewed once.
Precautions for use
This is a medical device which should be used as part of a healthy lifestyle and should not be used as a substitute for a diversified and balanced diet. Do not bite or chew the gelatine capsules or let them dissolve in your mouth. Do not exceed the dose given in the Recommendations for use. Keep out of reach of children. Store in a dry place at room temperature, away from exposure to light.
This medical device may have an impact on your blood sugar levels. If you have diabetes you should firstly speak with your doctor prior to taking this treatment. In the event you are on any other form of treatment, consult with your doctor or pharmacist before taking this treatment. You should leave some space between taking Oenobiol Bindor 3-in-1+ and other medicinal products (such as contraceptives), vitamins or essential fatty acids. Leave a window of four hours between taking the two products. For the purposes of maintaining a diet rich enough in essential fatty acids and fat-soluble vitamins (A, D, E and K) you should not take Oenobiol Bindor 3-in-1 with more than two meals per day. Do not take more than four gel tablets a day.
(1) In vitro assessment of the efficacy of the patented fibre complex on four fatty products (chocolate, brioche, pistachio nuts and crisps).
(2) In vitro assessment of the efficacy of the patented fibre complex on a complete meal.
(3) Assessment of the short-term prebiotic effect of the patented fibre complex.
(4) Study conducted on a panel of 25 people over the course of 30 consecutive days.
See package leaflet.
Do not take if your body mass index (BMI) is under 18.5. For adults only. Do not take if you are pregnant or breastfeeding without firstly seeking medical advice. Do not take if you are allergic to carrots, oats or apples. Do not take if you are allergic to any of the ingredients in the formulation or you are known to not tolerate any of them well. Speak with your pharmacist before taking this product.
This medical device is a regulated health product; as such and pursuant to regulation it bears the “CE” mark. Manufactured by Laboratoires CLEMASCIENCE, 3 place des prêcheurs, 13100 AIX-EN-PROVENCE. Carefully read the package leaflet before use. Not covered by healthcare insurance.
100% plant-derived fibre complex; gelatine capsule: hydroxypropyl methylcellulose (plant-derived coating); anti-caking agent: magnesium stearate.
This complex does not contain preservatives.
CONTAINS OAT – GLUTEN FREE.
Mechanism of action
When taken first thing at the start of lunch or dinner the patented complex contained in the gel tablets forms a mesh-like netting which expands in the stomach to capture part of the fat and sugar from food intake(1,2). In doing it so it also reduces the absorption of part of the calories consumed(1,2). Elimination occurs via natural routes. The prebiotic effect is achieved from a new fibre complex which rebalances the intestinal flora to make it more hospitable for beneficial bacteria(3) (such as Bifidobacterium and Bacteroidetes). These flora are responsible for weight loss so, once restored, produce a slimming effect.
Oenobiol Bindor 3-in-1+ has been the subject of various studies (both in vitro and clinical) to ensure its efficacy is proven.
(3) Assessment of the short-term prebiotic effect of the patented fibre complex. Study no. 2015190/D252/5, 01/2017.